meta_pixel
Tapesearch Logo
Log in
Public Health On Call

192 - An Update on COVID-19 Treatments: Monoclonal Antibodies, Convalescent Plasma, Remdesivir and More

Public Health On Call

The Johns Hopkins Bloomberg School of Public Health

Medicine, News, Health & Fitness

4.6644 Ratings

🗓️ 2 November 2020

⏱️ 15 minutes

🧾️ Download transcript

Summary

COVID-19 mortality rates are falling and better treatments are one of the main reasons why. Dr. Arturo Casadevall returns to the podcast to talk with Stephanie Desmon about where we are with different treatments and their successes, ongoing clinical trials, why some treatments are harder than others to produce, and whether we'll continue to see investments in treatments when a vaccine is available.

KEYWORDS: COVID-19 therapy; vaccine authorization; immune response

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to Season 2 of Public Health On Call, a podcast from the Johns Hopkins

0:11.6

Bloomberg School of Public Health.

0:13.6

I'm Joshua Sharfstein, Vice Dean for Public Health Practice and Community Engagement,

0:18.8

and a former secretary of Maryland's Health Department.

0:21.9

Our goal is to bring scientific evidence and experience to the public health news of the day

0:27.3

through informative interviews with scientists, community leaders, policy experts, public health

0:32.7

officials, clinicians, and more. If you have ideas or questions for us to cover, please email us at

0:39.8

Public Health Question at jhhhu.edu. That's public health question at jhhu.edu for future

0:47.2

podcast episodes. Today, Stephanie Desmond talks to Dr. Arturo Casa Deval, the chair of the

0:53.7

Department of Molecular Microbiology

0:55.7

and Immunology at Johns Hopkins.

0:58.1

COVID mortality rates are falling,

1:00.1

and they discuss what may be a reason why, better treatments.

1:04.2

They cover monoclonal antibodies, convalescent plasma,

1:07.6

and ramesivir, as well as what is in the pipeline.

1:11.8

Let's listen.

1:15.3

Arturo Casa Deval, thanks so much for joining me.

1:16.2

Thank you, Stephanie.

1:20.2

So today I'd like to talk a little bit about treatments for COVID.

1:23.9

We are seeing that mortality rates are going down.

1:25.4

Are treatments the reason?

1:29.9

Yes, I think that, well, there are two major reasons that mortality is going down. First, a lot of the people who are getting COVID today are younger,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Johns Hopkins Bloomberg School of Public Health, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Johns Hopkins Bloomberg School of Public Health and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.